Digestive Disease Interventions 2021; 05(04): 302-306
DOI: 10.1055/s-0041-1730408
Review Article

Cholecystectomy during COVID-19: A Single-Center Experience

Autoren

  • Martin Nnaji

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom
  • David Murcott

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom
  • Hrishikesh Salgaonkar

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom
  • Adebimpe Aladeojebi

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom
  • Tejinderjit Athwal

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom
  • Chandra V. N. Cheruvu

    1   Department of Surgery, University Hospital North Midlands, Stoke-on-Trent, United Kingdom

Funding None.

Abstract

COVID-19 pandemic has impacted health care globally with restructuring and prioritization of health care services. We prospectively analyzed 104 patients who underwent laparoscopic cholecystectomy during the peak of COVID-19 in 2020 and compared with 217 patients from the same period in 2019. Emergency admissions constituted majority of cases with no statistical difference between both groups (p = 0.49). Most cholecystectomies were for biliary colic (41.3 vs. 35.5%) and cholecystitis (37.5 vs. 43.8%) without any statistically difference (p = 0.31 and p = 0.29, respectively). This study demonstrates that laparoscopic cholecystectomy was feasible and safe in patients with symptomatic gall bladder disease during the peak period for COVID-19.

Presentation at a Meeting

None.




Publikationsverlauf

Eingereicht: 17. Dezember 2020

Angenommen: 06. April 2021

Artikel online veröffentlicht:
31. Mai 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA